The five-year project funded by the National Institute of Allergy and Infectious Diseases will involve three projects to investigate factors that accelerate and prevent the re-emergence of HIV.
There is no drug or vaccine to treat or prevent KSHV, which causes cancer, but the researchers showed that an inhibitor could be developed to break it down.
Protein-imaging method developed by new UCLA researcher overcomes challenges of current techniques, offering untold potential in the exploration of disease and treatment.
The researchers believe this to be the first national study comparing statin use in patients with and without HIV and the first extensive analysis using U.S. data.
A team of researchers from the UCLA Center for AIDS Research, Stanford University and the National Institutes of Health developed a synthetic molecule that could awaken dormant virus cells and then knock them out.
The researchers concluded that the UNAIDS approach would not be practical because it would require finding and treating a very large number of people in remote areas.
New UCLA-led research shows which strains of viruses that are transmitted depend on whether transmission occurs during pregnancy or through breastfeeding.
UCLA and the Los Angeles LGBT Center have developed a risk calculator that could help men who have sex with men decide whether to take pre-exposure prophylaxis.
The project supports interdisciplinary teams in their work to identify and test approaches for curing people infected with HIV who have established latent reservoirs of the virus.
Many midlife and older gay men experience the stress of being part of a sexual minority group. They perceive that they need to conceal their sexual orientation, or that others are uncomfortable with or avoid them because they are gay.
The researchers chalk up Denmark’s success to many factors, including the country’s universal health care system and the availability of free treatment for all people who have been infected with HIV.
The finding could be a cause for concern because many countries rely on the agency to help pay for vital health care services for people with the diseases.